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Objective: In Iran, psychological aspect of HIV infection is poorly understood. The purposes of this study were to 
evaluate sexual dysfunction, depression rate and health-related quality of life and evaluate the association between 
sexual dysfunction, depression and quality of life in a group of HIV+ subjects in Shiraz, Iran. 
Methods: In this cross-sectional study, 278 male HIV-positive patients who had referred to voluntary counseling and 
testing and methadone maintenance therapy centers were recruited based on convenience sampling from May to 
October 2010. The purpose of the study was explained and interested individuals provided informed consent and 
completed validated questionnaires [Medical Outcomes Study Short Form-36 (SF-36), Brief Male Sexual Function 
Inventory (BMSFI),  Beck Depression Inventory-short form(BDI)] to assess overall health related quality of life 
(HRQOL), sexual function, and depression. 
Results: Average age of the participants was 34.9 ± 10.7 years and 37.5% were severely depressed. Ordinal logistic 
regression indicated that sexual drive (-0.15; CI: -0.28 to -0.027), ejaculation (-1.91, CI: -2.71 to -1.12), and problem 
assessment (-0.098, CI: -0.17 to -0.02) had significant effect on depression type. Depression was significantly correlated 
with poorer quality of life in all domains. Pearson’s correlation coefficients between the BMSFI and the domains of SF-
36 indicated that sexual drive (r= 0.215), ejaculation (r= 0.297) and problem assessment (r= 0.213) were significantly 
correlated with emotional wellbeing. 
Conclusion: Sexual function and depression showed association with quality of life. Effective treatment of depression 
and sexual function may improve the quality of life of HIV-infected person. 
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•Introduction 
exual dysfunction has been widely 
reported among men living with HIV 
infection and also HIV uninfected 
men. Studies demonstrated that between 13% 
and 74% of HIV+ men in the highly active 
antiretroviral therapy suffering from sexual 
dysfunction (1). In Iran, although, persons 
with HIV infection usually suffer from 
sexual dysfunction, but its frequency and 
Authors’ affiliations: *Shiraz HIV/AIDS Research Center, Shiraz 
University of Medical Sciences, Shiraz, Iran. ** Namazi  Hospital , 
endocrine & Metabolism research center, Shiraz University of 
Medical Sciences, Shiraz-Iran.*** school of public health, Bushehr 
University Of Medical Sciences, 
Bushehr , Iran. **** Health Policy  Research Center Shiraz 
University of Medical Sciences, Shiraz, Iran. 
●Corresponding Author: Maryam  Marzban, PhD student in 
Epidemiology, School of Public Health, Bushehr  University Of 
Medical Sciences, Bushehr , Iran.  
Tel: +98 9178204991 
Fax: 07714550134  
Email: marzbanh@gmail.com 
manifestations in this population is not well 
known (2). Both organic and psychological 
factors have been identified as the causal 
factors for sexual dysfunction (3). Indeed, 
poor emotional and psychological functions 
among people living with HIV, may lead to 
sexual dysfunction (4). The psychological 
aspects of sexual dysfunction may take on an 
added dimension in patients with HIV 
infection. Regardless the mode of transmission, 
HIV-positive patients may be upset with the 
risk of transmitting HIV to others. So, 
psychological issues as a cause or an effect 
of sexual dysfunction should be considered 
by clinicians for better handling of HIV+ 
patients (3). Sexual dysfunctions moreover 
are conceptualized as one component of 
sexual health, which is an essential element of 
overall health related quality of life (HRQOL). 
S 
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Sexual health encompasses the possibility of 
having pleasurable and safe sexual 
experiences (5). 
Sexual dysfunction has been widely reported 
among men living with HIV infection and 
also HIV uninfected men. Studies 
demonstrated that between 13% and 74% of 
HIV+ men in the highly active antiretroviral 
therapy suffering from sexual dysfunction (1). 
In Iran, although, persons with HIV infection 
usually suffer from sexual dysfunction, but 
its frequency and manifestations in this 
population is not well known (2). Both 
organic and psychological factors have been 
identified as the causal factors for sexual 
dysfunction (3). Indeed, poor emotional and 
psychological functions among people living 
with HIV, may lead to sexual dysfunction (4). 
The psychological aspects of sexual 
dysfunction may take on an added dimension 
in patients with HIV infection. Regardless 
the mode of transmission, HIV-positive 
patients may be upset with the risk of 
transmitting HIV to others. So, psychological 
issues as a cause or an effect of sexual 
dysfunction should be considered by 
clinicians for better handling of HIV+ 
patients (3). Sexual dysfunctions moreover 
are conceptualized as one component of 
sexual health, which is an essential element 
of overall health related quality of life 
(HRQOL). Sexual health encompasses the 
possibility of having pleasurable and safe 
sexual experiences (5). 
 
Depression 
Not only physical manifestations, but 
psychological health is also negatively 
affected in individuals living with 
HIV/AIDS. The prevalence of depression in 
the HIV population remains high and should 
be continually addressed. Among individuals 
with HIV disease, major depression is a 
frequently observed psychiatric disorder. 
However, the relationships between HIV and 
depression are very complex and difficult to 
assess (6). 
 The symptoms of depression are similar in 
HIV-infected and non-infected patients, but 
patients with HIV infection may more 
frequently have sleep and appetite 
disturbances. Patients with a history of 
depression, homosexual men, women, and 
intravenous drug abusers are among HIV-
infected individuals who may be at increased 
risk for depression (7). As the number of 
persons living with HIV continues to grow, it 
is essential to explore the prevalence of HIV-
related depression, as well as the factors that 
contribute to the depression. Some studies 
indicate a large range of prevalence rates of 
depression in HIV, with reports ranging from 
5% to 45% (6-10).  
 
Quality of life 
Quality of life is an important component in 
the evaluation of the well-being of HIV-
infected patients (11). Although medical 
aspects of HIV/AIDS are well documented, 
self-reported HRQOL measures are less well 
understood, particularly among those patients 
with advanced disease (12). HRQOL refers to 
how well a person functions and to his or her 
perceptions of well-being in the physical, 
mental, and social domains of life (13). 
Assessing HRQOL is useful for documenting 
the burden of chronic disease, following 
changes in health over time, and comparing 
the overall effects of treatments (14). Quality 
of life is an important component in the 
evaluation of patients well-being following 
HIV infection. Improving quality of life is a 
major goal in treating individuals infected 
with HIV. Measuring HRQOL is accepted as 
capturing the overall impacts of interventions 
on patients’ functioning and wellbeing, which 
goes beyond the interpretability and clinical 
meaning of immunologic and virologic 
markers (15). Many studies have investigated 
HRQOL in patients with HIV (16-18), and 
some have assayed the association between 
HRQOL and depression (19). As Felton et al. 
have shown HRQOL is the single most 
important predictor of depression. Another 
study demonstrated that reduction in 
depression lead to a significant improvement 
in HRQOL with the exception of work and 
financial functioning (20). 
To the best of our knowledge, no studies 
have reported depression rate, sexual 
dysfunction, and HRQOL of people living 
with HIV and their associations to each other 
71 Iran J Psychiatry Behav Sci, Volume 7, Number 2, Autumn/Winter 2013                                                                  
www.ijpbs.mazums.ac.ir 
Depression & Quality of Life in HIV+ Patients 
in Iran. This paper describes sexual 
dysfunction, depression and HRQOL and 
evaluates the impact of sexual dysfunction on 
depression and quality of life in a group of 
HIV-positive subjects in Shiraz, Iran.  
 
Materials and Methods 
Sample 
From 315 participants a total of 278 HIV-
positive patients were recruited based on 
convenience sampling from May to October 
2010 with a response rate of over 88 percent. 
Data were collected from Voluntary 
Counseling and Testing Center (VCT) and 
MMT center, related to Shiraz University of 
Medical Sciences, Shiraz, Iran.  
The purposes of the study were explained for 
all participants and interested individuals 
provided informed consent and completed a 
questionnaire detailing socio-demographic 
and HIV related variables and validated 
questionnaires to assess sexual function, 
depression and health related quality of life. 
This procedure was administered to the 
subjects when they came to the VCT and 
MMT centers, Shiraz, Iran. 
 
Tools: SF-36 
To assess HRQOL the Medical Outcomes 
Study Short Form-36 (SF-36) was used.  
This self-administered includes one multi-
item scale that assesses eight health  
concepts: limitations in physical activities 
because of health problems (e.g., walking, 
dressing), limitations in social activities 
because of physical or emotional problems 
(e.g., meeting friends), limitations in usual 
role activities because of physical health 
problems, bodily pain (presence of pain and 
limitations due to pain), general mental 
health (psychological distress and well-
being), limitations in usual role activities 
because of emotional problems, vitality (loss 
of energy or presence of fatigue), and general 
health perceptions (5). Each HRQOL domain 
is given a score ranging from 0 to 100, with 
higher scores indicative of better quality of 
life (21). In this study quality of life data were 
collected through computerized scoring 
software. 
 
Brief Male Sexual Function Inventory 
(BMSFI) 
To assess sexual dysfunction, the Brief Male  
 
Sexual Function Inventor (BMFSI) was used. 
This instrument consists of 11 questions with 
5 possible responses scored on a scale of 0 
(worst) to 4 (best). These questions are 
summarized into 5 domains, including sexual 
drive (questions 1 and 2), erectile function 
(questions 3 to 5), ejaculatory function 
(questions 6 and 7), problem assessment 
(questions 8 to 10) and overall sexual 
satisfaction (question 11). The value of each 
domain reflects the simple algebraic sum of 
the scores of the underlying question(s) with 
lower domain scores indicate more impaired 
sexual function (22). 
 
Beck Depression Inventory-short form (BDI) 
The Beck Depression Inventory II (BDI-II) 
was used to assess the prevalence and 
severity of depressive symptoms. The BDI-II 
has shown high validity and reliability in 
measuring depressive symptoms. Respondents 
were required to rate 21 items from 0 to 3 
according to how they had felt during the 
previous 2 weeks. The BDI-II focuses on 
both the cognitive-affective symptoms of 
depression, such as pessimism and 
diminished self-esteem, and the somatic 
symptoms of depression such as weight loss 
(23). The questionnaires described above all 
have been validated in previous studies (23, 
24). 
 
Data Analysis 
The data were analyzed using the Statistical 
Package for the Social Sciences (SPSS) for 
Windows, Version 18.0. We carried out a 
simple descriptive analysis of the patients’ 
perception of their quality of life, sexual 
dysfunction and depression and demographic 
variables. The Pearson's correlation 
coefficients (r) and ordinal logistic regression 
were used for analysis. 
 
Results 
Study Participation and Participant 
Characteristics 
A total of 278 patients were included in the 
study. All patients included in this study had 
received a diagnosis of HIV infection. Patient 
www.ijpbs.mazums.ac.ir                                                                      Iran J Psychiatry Behav Sci, Volume 7, Number 2, Autumn/Winter 2013   
72 
Amini Lari M   ,   Faramarzi H   ,   Shams M   ,   et al.   
characteristics are presented in table 1. The 
mean age was 37.4 (SD±7.4) years, all of 
them were male and 84.2% were 
unemployed.  
Table 1. Characteristic of 278 HIV-seropositive patients in 
Shiraz, Iran 
 
Characteristic Frequency Percentage 
Age group (in year) 
25-30 
30-40 
41 and older 
Missing Data 
 
025 
132 
086 
035 
 
09% 
47.5% 
30.9% 
12% 
Marital statues 
Single 
Married 
Separated 
Divorced 
Live with permanent partner 
Live with temporary partner 
Missing Data 
 
119 
094 
022 
009 
005 
002 
027 
 
42.8% 
33.8% 
07.9% 
03.2% 
01.8% 
00.7% 
09.7% 
Employment status 
Un Employed 
Employed 
 
234 
044 
 
84.2% 
15.8% 
Level of education 
Illiterate 
Primary school and secondary 
school 
High school 
Higher than high school diploma 
Missing Data 
 
030 
123 
057 
024 
044 
 
10.8% 
44.2% 
20.5% 
08.7% 
15% 
Cigarette smoking 
Yes 
No 
Missing Data 
 
227 
043 
008 
 
81.7% 
15.5% 
02% 
Methadone maintenance therapy 
Yes 
No 
Missing Data 
 
114 
162 
002 
 
41% 
58.3% 
00.7% 
Entering the AIDS stage 
Yes 
No 
Missing Data 
 
188 
084 
006 
 
67.6% 
30.2% 
00.2% 
 
 
Mean, Standard deviation and score range for 
five domains of BMSFI are presented at table 
2. 
Among the 278 HIV-seropositive subjects 
enrolled, 211 (75.9%) patients were diagnosed 
to be depressed and 79(37.5%) were severely 
depressed. The prevalence of diagnosed 
depression among the population of 278 
HIV-positive patients appears in figure 1. 
 
Pattern of drug abuse and depression 
One-hundred sixteen (42%) were receiving 
methadone at the time of study. Among non 
methadone users (162 cases) the illicit 
substances abused were heroin (49 cases, 
30.2%), opium (19 cases, 11.5%), marijuana 
(3 cases, 2.1%), and a combination of 
multiple illicit drugs (41 cases, 25%). 
Substances of abuse were not defined in52 
cases (31.2%). According to the univariate 
analysis, there was no significant association 
between depression and pattern of drug 
substance abuse (p=0.103). There was no 
statistically significant difference regarding 
depression rate between those who were 
receiving methadone and others (p= 0.142). 
 
Table 2. Mean, standard deviation and score range for 
five domains of BMSFI among 237 HIV-seropositive 
patients 
 
 Range Mean (±SD) 
Sexual drive 0-08 3.7 (±1.92) 
Ejaculation 0-12 6.36 (±2.7) 
Erection 0 - 8 5.2 (±2.19) 
Problem assessment 0-12 8.04 (±3.63) 
Overall satisfaction 0-04 2.42 (±1.05) 
 
 
 
 
Figure 1. Severity of depression among 278 HIV-
infected patients studied 
 
 
Effect of sexual dysfunction on depression 
Firstly, according to depression scores, we 
categorized the subjects into two groups. A 
BDI-II score of more than 18 was chosen as 
the cut-off point to distinguish patients with 
moderate to severe depression from those 
with normal or only minimally elevated 
depression scores. 
 Then, the association between five domains 
of the BMSFI and depression was 
investigated using binary logistic regression. 
The results indicated that sexual drive (OR= 
0.84; CI: 0.71- 0.99) and problem assessment 
(OR=0.883; CI: 0.80-0.97) had significant 
effect on the presence of depression (Table 
3). 
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Table 3. Effect of sexual dysfunction on depression 
among 273 HIV+ men 
Sexual function Odds Ratio 
Confidence 
Interval P-Value 
Sexual drive 0.84 0.71 -0.99 0.038 
Erection 0.91 0.80-1.03 0.142 
Ejaculation 0.86 0.73-1.02 0.092 
Problem assessment 0.883 0.80-0.97 0.011 
Overall satisfaction 0.98 0.95-1.012 0.25 
According to the  results of evaluating sexual 
dysfunction, the mean and standard deviation 
of 8 health concepts of SF36 were as follow: 
limitations in physical activities because of 
health problems (e.g., walking, dressing) 
(32.6±25), limitations in social activities 
because of physical or emotional problems 
(e.g., meeting friends) (45.6±43.7), 
limitations in usual role activities because of 
physical health problems (55.11±55), bodily 
pain (presence of pain and limitations due to 
pain) (51,31±50), general mental health 
(psychological distress and well-being) 
(46.3±43.7), limitations in usual role 
activities because of emotional problems 
(42.5± 40.7), vitality (loss of energy or 
presence of fatigue)(43.08±45), and general 
health perceptions (48.3± 50). 
 
Correlation of BMSFI with SF-36 scales 
The Pearson’s r correlation coefficients 
between the BMSFI and the domains of SF-
36 in all 278 patients indicated that emotional 
well being was correlated with sexual drive 
(r= 0.215, p= 0.006), ejaculation (r= 0.297, 
p< 0.0001) and problem assessment (r= 
0.213, p= 0.004). Likewise, significant 
associations were detected between general 
health and ejaculation (r= 0.155, p= 0.046) 
and between social functioning and problem 
assessment (r= 0.192, p= 0.01). 
 
Correlation of depression with SF-36 scales 
Table 4 shows the Pearson’s r correlation 
coefficients between depression and the SF-
36 composite subscales. There was statistical 
significance between all domains of the SF-
36 and type of depressive disorder and 
emotional well being had the strongest 
correlation was observed with depression 
type (r= 0.452).  
 
 
Table 4. The Pearson’s r correlation coefficients 
between the type of depression and SF36 subscales 
among 278 HIV+ patients  
 
 r p 
Physical functioning 0.386 < 0.0001 
Role limitation due to physical health 0.285 < 0.0001 
Pain 0.443 < 0.0001 
General health 0.220    0.001 
Energy/fatigue 0.413 < 0.0001 
Social functioning 0.408 < 0.0001 
Role limitation due to emotional 
problems 
0.324 < 0.0001 
Emotional well being 0.452 < 0.0001 
Discussion 
In Iran the epidemiology of sexual 
dysfunction in HIV/ADS patients and its 
relationship to quality of life and depression 
in this population are poorly understood. The 
purpose of our study was to determine the 
prevalence of depression and sexual 
dysfunction and to measure HRQOL and to 
evaluate the impact of sexual dysfunction on 
depression and quality of life in a group of 
HIV-positive subjects in Shiraz, Iran.  
Sexual health is defined in terms of well-
being, but is challenged by the social, 
cultural and economic realities faced by men 
with HIV (25). Sexual dysfunctions are 
considered as main part of sexual health, 
which is an essential element of overall 
HRQOL (5). Depressive disorders are 
common among 20% to 32% of people with 
HIV but often are not identified well (26). In 
our study most of the patients were 
depressed. In similar studies held in Denmark 
and Australia, symptoms of depression (i.e., 
BDI> 14) have been observed among most 
HIV-infected patients (23-27). The results of 
present study revealed that the rate of 
depression was higher in comparison to the 
mentioned studies. The findings approve that 
depression is less diagnosed and treated in 
HIV-infected patients. Sexual dysfunction is 
often implicated in depression and anxiety 
disorders and it is more common in 
depressed patients (28). Most patients 
suffering from mild, moderate, or major 
forms of depression experience sexual 
dysfunction simultaneously (29).  
For a long time, the sexual behavior of HIV-
infected persons did not receive any serious 
attention (30). Our result showed that 
depressed patients significantly had lower 
scores in some domains of BMFSI and by 
increasing score of sexual drive and problem 
assessment the depression status become 
well.   
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Depression adversely affects QOL, and that 
effective treatment of depression may 
dramatically improve the QOL of HIV-
infected persons (31), and it is related to most 
indices of quality of life among HIV-positive 
adults. Thus, in HIV-infected persons, a 
subject’s experience of depressive symptoms 
is a good predictor of poor QOL. Depression 
adversely affects QOL, and that effective 
treatment of depression may dramatically 
improve the QOL of HIV-infected person 
(31). 
Our study indicated that depression was 
significantly correlated with all domains of 
quality of life. In a Nigerian study, patients 
with a clinical diagnosis of depression had 
significantly lower HRQOL scores in all 
domains except ‘social relationships (10). 
Some other studies demonstrated association 
between depression and quality of life among 
HIV+ patients (19, 20). 
On the other hand sexual function has been 
recognized as a crucial component of health, 
in fact experience of sexual dysfunction is 
generally associated with poor quality of life 
(32). According to our findings about the 
relationships between some components of 
QOL and some domains of BMSFI, by 
improving sexual function HRQL can 
increased and this should be an important 
goal for clinicians involved in the care of 
HIV-infected individuals. 
The present study is limited by its lack of 
conscious participants because of their poor 
socio- economical status such as low 
educational level, unemployment, poor social 
and family support and addiction and also the 
content of BMSFI, so data collection was so 
hard in this group and missing data is 
expected. These variables have not been 
taken into account though available 
literatures suggest that they influence quality 
of life significantly, sexual dysfunction and 
depression. Age, marital status and education 
that are significantly associated with quality 
of life, have also not been controlled in the 
present study. Due to the cross-sectional 
design, the findings point more toward an 
association rather than cause and effect. 
Various psychological symptoms are 
associated with HIV infection and associated 
with quality of life, sexual dysfunction and 
depression; these factors are not taking into 
account in the present study too. 
In conclusion we suggest future studies to 
evaluate our variables in female HIV-
infected patients and comparison according 
to gender differences, also we offer 
administration randomized clinical trial to 
evaluate effect of endocrine treatment like 
testosterone therapy on sexual dysfunction 
for promoting health related quality of life in 
people who live with HIV.  
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